Diabetologia

Exogenous insulin and risk of all-cause mortality in type 2 diabetes: a dose-response association

https://www.easd.org/virtualmeeting/home.html?fbclid=IwAR0b8fdQdqu2d_4wQPySEbYhtpKc1I9VzGkQLIS0wOyL0uF0DD1X_LqcBEY#!resources/exogenous-insulin-and-risk-of-all-cause-mortality-in-type-2-diabetes-a-dose-response-association–2

Post author By Holden S E, Schernthaner G, Jenkins-Jones S and Currie C J
Post date 27 September 2013

Holden S E, Schernthaner G, Jenkins-Jones S, Currie C J. 27 Sep 2013

Holden S E

Schernthaner G

Jenkins-Jones S

Currie C J

Transforming real-world data into transparent, reliable, and reliable real-world evidence

44 (0) 2920 782856

enquiries@humandatasciences.com

24 Wordsworth Avenue, Cardiff, CF24 3FR United Kingdom

Copyright Pharmatelligence Limited (trading as Human Data Sciences) is a Private Limited Company (PLC) registered in England and Wales with Company Number 7107514.

Livingstone® is a Trusted Research Environment (TRE)

Quick Links

Transforming real-world data into transparent, reliable, and replicable real-world evidence

44 (0) 2920 782856

instantRWE@humandatasciences.com

The Global Pharma Research Centre,
24 Wordsworth Avenue, Cardiff, CF24 3FR United Kingdom

Copyright Pharmatelligence Limited (trading as Human Data Sciences) is a Private Limited Company (PLC) registered in England and Wales with Company Number 7107514.

Livingstone^® is a Trusted Research Environment (TRE)

Web Design – Create Summit

Site by Create Summit